Osteopontin (OPN) plays a role in T cellmediated immunity, but its involvement in Th2-associated allergic responses, especially asthma, has not been investigated. This cross-sectional casecontrol study was designed to determine whether serum OPN levels are elevated in asthma patients and whether these correlated with disease severity. Serum samples were obtained from patients with mild (n = 42), moderate (n = 48) and severe (n = 39) asthma, and 41 healthy control subjects. OPN protein concentrations were measured by enzyme-linked immunosorbent assay and were found to be significantly higher in all three asthma patient groups compared with healthy controls. There was no significant association between OPN concentration and disease severity. The data suggest a role for OPN in the pathogenesis of asthma. Further studies are needed to clarify the involvement of OPN in various aspects of asthma.
Introduction
Osteopontin (OPN), also known as early Tlymphocyte activation 1, is a phosphorylated acidic glycoprotein implicated in several physiological and pathological events. 1 The mechanism of action of OPN remains to be fully defined, but it appears to play a role in T cellmediated immunity. 2 -5 High levels of OPN have been observed in several T-helper type 1 (Th1) associated diseases, including rheumatoid arthritis and multiple sclerosis. 6, 7 Granulomatous responses and pulmonary fibroses are also associated with increased OPN levels. 8, 9 The involvement of OPN in T-helper type 2 (Th2) associated allergic responses has not yet been investigated.
Asthma is characterized by eosinophilic airway inflammation and is regarded as a typical Th2-associated allergic disease. 10 It exhibits several potential pathogenic mechanisms including enhancement of the Th2 immune response, migration of eosinophils into the airway, airway mucus production and airway remodelling. 11 Increased OPN levels have been detected in the tear fluid of patients with allergic ocular diseases 12 and in lung biopsies from asthmatic individuals. 13 The elevated OPN levels found in subepithelial inflammatory cells of asthmatic airways suggests that eosinophils may be a cellular source of this mediator. 14 Venom immunotherapy has been shown to increase OPN levels significantly, 15 and animal studies demonstrate that OPN levels are increased in allergen-induced chronic airway remodelling, whereas OPN J-J Zhao, L Yang, F-Q Zhao et al. deficiency  protects  against  airway  remodelling  and  bronchial hyperresponsiveness. 16 Taken together, these findings suggest a potential role for OPN in the regulatory pathway of Th2-associated allergic responses, especially asthma.
Osteopontin in asthma
The aims of the present study were to determine if serum OPN levels were elevated in asthma patients and whether OPN levels were correlated with the severity of disease.
Patients and methods

PATIENTS
In this cross-sectional, case-control study, subjects aged ≥ 18 years were recruited from the asthma clinic of the China-Japan Union Hospital of Ji Lin University, Changchun, China, between November 2009 and October 2010. Detailed clinical histories and physical examinations were performed on all subjects. The diagnosis of asthma was based on the criteria of the American Thoracic Society. 17 Sex-and age-matched volunteers were recruited as control subjects. Control subjects had no history of allergy and were free from respiratory diseases such as asthma, chronic obstructive pulmonary disease or bronchiectasis. Asthma patients were tested for atopy by skin-prick testing and were free from respiratory tract infections for a minimum of 4 weeks before inclusion in the study.
The study was approved by the Ethics Committee of the China-Japan Union Hospital of Ji Lin University and informed consent was obtained from all participants.
PULMONARY FUNCTION
Spirometric tests and assessments of asthma severity were carried out in accordance with National Institutes of Health (NIH)/World Health Organization (WHO) guidelines. 18 Spirometry was carried out using a MasterScreen™ IOS spirometer (Jaeger, Hoechberg, Germany) and the best value of three tests was expressed as a percentage of the predicted value. Patients were divided into three groups according to the severity of their disease (mild, moderate, severe) using the NIH/WHO guidelines. 18 
ATOPIC STATUS
A commercially available skin prick test (HAL Allergy Group Benelux, Leiden, The Netherlands) to any of 20 common aeroallergens (including mites, grasses, trees, fungi and domestic animals) was used to confirm atopy.
SAMPLE COLLECTION
Approximately 20 ml of peripheral blood was obtained from each of the healthy controls and asthma patients. Serum was separated from peripheral blood by microcentrifuge at 1008 g at room temperature and stored in aliquots at -80°C until analysis. 
MEASUREMENT OF SERUM OPN
Results
The demographic and clinical characteristics of the asthma patients and healthy controls are shown in Table 1 ; both groups were comparable for age and gender distribution.
The OPN levels were significantly higher in the three asthma patient groups compared with the healthy control subjects (P < 0.01) ( Table 1) . Levels also increased with the severity of asthma, but this was not statistically significant ( Fig. 1 ).
Discussion
Osteopontin is an extracellular matrix protein with a wide range of functions and is an important mediator of physiological and pathological processes throughout the body. 5 It contains arginine-glycine-aspartate and SVVYGLR (SLAYGLR in murine osteopontin) domains that bind various integrins and facilitate the adhesion and migration of inflammatory cells such as macrophages, monocytes, lymphocytes and neutrophils. 19 -22 Studies of OPN-deficient mouse models and neutralizing antibodies have demonstrated the importance of OPN in the development of several inflammatory diseases, particularly those involving Th1-associated immune responses, 20,23 -25 because it 6 -8,26,27 Although OPN is mainly involved in Th1-associated disease, its contribution to Th2-associated disease has only been addressed relatively recently. Increased OPN levels have been detected in patients with chronic rhinosinusitis 28 and in the tear fluid of patients with allergic ocular disease. 12 Studies of endobronchial biopsies from asthma patients have found increased OPN immunostaining in the epithelial layer, as well as in eosinophils, macrophages and lymphocytes present in the submucosal inflammatory infiltrate. 13, 14 Xanthou et al. 13 found that OPN has a bimodal immunomodulatory effect in a murine model of allergen-induced airway inflammation: a Th2-enhancing effect was observed during antigenic sensitization, and a Th2-repressor effect was seen during antigen challenge. These effects are mediated by the inhibition of migration of plasmacytoid and conventional dendritic cells, respectively. In this model, administration of recombinant OPN during antigen challenge protected mice from allergic disease. In addition, Takahashi et al. 29 reported that OPN is present in the airways of asthma patients and that the OPN protein concentration is positively correlated with the percentage of eosinophils in induced sputum. Anti-OPN antibodies have been shown significantly to attenuate ovalbumin-induced eosinophilic airway inflammation in mouse models of allergic asthma. 29 Osteopontin has also been implicated in fibrosis formation in damaged tissue. 30 Findings by Kohan et al. 14 demonstrated that OPN is upregulated in a murine model of allergen-induced airway remodelling and that the presence of OPN is correlated with 31 also found that mast cells produce OPN, and that OPN induces chemotaxis and degranulation of these cells. Taken together with the report by Simoes et al., 16 which found that OPN deficiency protects against airway remodelling and hyper-responsiveness in chronic asthma, it seems that OPN may play a multifunctional role in asthma. There is currently no effective treatment for airway remodelling; however, the effect of OPN on allergic response suggests a possible role as a novel therapeutic target in asthma remodelling. The present study demonstrated that asthma patients exhibit higher serum OPN levels than healthy control subjects, suggesting a role for this protein in asthma pathogenesis. Contrary to the study hypothesis and the report of Delimpoura et al., 32 there was no association between OPN concentration and disease severity. The role of OPN in asthma appears to be counterintuitive. There are contradictory reports regarding the contribution of OPN in several inflammatory conditions and dual roles for this molecule in a single disease have been also reported. 1,13,25,33 -36 These phenomena may be explained by the role of OPN in inflammatory responses, which is complex due to its complicated structure and the existence of several functional motifs.
The present study did not examine bronchial biopsies, which would have allowed the more precise analysis of the presence and location of OPN protein via immunohistochemistry, as well as quantitative reverse transcriptionpolymerase chain reaction for evaluation of OPN mRNA levels.
In conclusion, the present study showed for the first time that asthma patients exhibit higher serum OPN levels than healthy controls, suggesting a role for this protein in the pathogenesis of asthma. There was, however, no association between OPN concentration and disease severity. Further studies are needed to clarify the involvement of OPN in various aspects of asthma.
